G

General Proximity

Winter 2020
www.generalproximity.bio/HealthcareSan Francisco, CA, USA

Investor read

Evidence-bound summary — expand sections for movement, risks, and signals.

Memo snapshot · May 19, 2026, 8:21 PM

What they do

Next-Gen Proximity Medicines | General Proximity General Proximity pioneers next-generation medicines by controlling biological processes through proximity

Quick read

  • Next-Gen Proximity Medicines | General Proximity General Proximity pioneers next-generation medicines by controlling biological processes through proximity
  • Reported angle: Latest News & Insights | General Proximity
  • Indexed activity snapshot: 0 funding‑related row(s), 1 hiring‑related, 0 GitHub‑tagged, 2 product/news‑style — scoring reflects corpus coverage only.

Stage

Unknown

Evidence summary

Verified facts

  • Next-Gen Proximity Medicines | General Proximity General Proximity pioneers next-generation medicines by controlling biological processes through proximity
  • Reported angle: Latest News & Insights | General Proximity
  • Indexed activity snapshot: 0 funding‑related row(s), 1 hiring‑related, 0 GitHub‑tagged, 2 product/news‑style — scoring reflects corpus coverage only.
Nexus growth score
40.0Early / quiet
7D+0%
30D+0%
Medium Confidence

Source health

  • public_market_enrichmentok
    Last checked Mon, May 11, 05:06 AM
  • public_page:_pressnot_found
    Last checked Mon, May 11, 05:06 AM

    HTTP 404

  • public_page:_newsok
    Last checked Mon, May 11, 05:06 AM
  • public_page:_jobsok
    Last checked Mon, May 11, 05:06 AM
  • public_page:_companynot_found
    Last checked Mon, May 11, 05:06 AM

    HTTP 404

  • public_page:_careersok
    Last checked Mon, May 11, 05:06 AM
  • public_page:_blogok
    Last checked Mon, May 11, 05:06 AM
  • public_page:_aboutnot_found
    Last checked Mon, May 11, 05:06 AM

    HTTP 404

  • public_page:_ok
    Last checked Mon, May 11, 05:06 AM
  • public_page:homeok
    Last checked Mon, May 11, 05:06 AM

Nexus score momentum

407D +030D +0
100500
2026-05-11: 40

More runs will build history.

Signal breakdown

Latest momentum signal per category. Expand a card to inspect raw payloads.

Score snapshots

Public source summary

Total evidence rows
6
Latest evidence
Mon, May 11, 05:06 AM

Source types found

blogcareers_pagenewsofficial_site

Public signal timeline

Newest first · 5 event(s)

1
Mon, May 11, 05:06 AM · blog · 90% · publichigh quality

Latest News & Insights | General Proximity

Source: Blog / news

Stay updated on General Proximity’s breakthroughs, news, and innovations in next-gen medicines redefining biology and drug discovery.

Source ↗
2
Mon, May 11, 05:06 AM · careers_page · 70% · publichigh quality

Careers in Next-Gen Medicine | General Proximity

Source: Careers

Join General Proximity and help redefine the future of medicine. Explore career opportunities in proximity-based drug innovation and groundbreaking biology.

Source ↗
3
Mon, May 11, 05:06 AM · official_site · 70% · publichigh quality

General Proximity | Armand B. Cognetta III | Substack

Source: Homepage

generalproximity.bio blog. Click to read General Proximity, by Armand B. Cognetta III, a Substack publication with thousands of subscribers.

Source ↗
4
Mon, May 11, 05:06 AM · official_site · 90% · publichigh quality

Next-Gen Proximity Medicines | General Proximity

Source: Homepage

General Proximity pioneers next-generation medicines by controlling biological processes through proximity. Redefining the future of medicine for all humankind.

Source ↗
5
Mon, May 11, 05:06 AM · news · 45% · publicmedium quality

General Proximity | LinkedIn

Source: Social (linked from site)

General Proximity | LinkedIn Skip to main content LinkedIn Top Content People Learning Jobs Games Sign in Join now

Source ↗

Official / company site

2 row(s)

official_site·Mon, May 11, 05:06 AM·Confidence 70%high qualitypublic

General Proximity | Armand B. Cognetta III | Substack

Source name: Homepage

generalproximity.bio blog. Click to read General Proximity, by Armand B. Cognetta III, a Substack publication with thousands of subscribers.

https://blog.generalproximity.bio/
official_site·Mon, May 11, 05:06 AM·Confidence 90%high qualitypublic

Next-Gen Proximity Medicines | General Proximity

Source name: Homepage

General Proximity pioneers next-generation medicines by controlling biological processes through proximity. Redefining the future of medicine for all humankind.

https://www.generalproximity.bio/

Hiring

1 row(s)

careers_page·Mon, May 11, 05:06 AM·Confidence 70%high qualitypublic

Careers in Next-Gen Medicine | General Proximity

Source name: Careers

Join General Proximity and help redefine the future of medicine. Explore career opportunities in proximity-based drug innovation and groundbreaking biology.

https://www.generalproximity.bio/careers

Social

1 row(s)

news·Mon, May 11, 05:06 AM·Confidence 45%medium qualitypublic

General Proximity | LinkedIn

Source name: Social (linked from site)

General Proximity | LinkedIn Skip to main content LinkedIn Top Content People Learning Jobs Games Sign in Join now

https://www.linkedin.com/company/generalproximity/

Blog

1 row(s)

blog·Mon, May 11, 05:06 AM·Confidence 90%high qualitypublic

Latest News & Insights | General Proximity

Source name: Blog / news

Stay updated on General Proximity’s breakthroughs, news, and innovations in next-gen medicines redefining biology and drug discovery.

https://www.generalproximity.bio/news
Noisy or blocked sources (1)Collapsed by default — expand to inspect
news·Mon, May 11, 05:06 AM·Confidence 45%noisypublic

The ARPA-H Sprint for Women’s Health | Armand Cognetta | 14 comments

Source name: Social (linked from site)

The ARPA-H Sprint for Women’s Health | Armand Cognetta | 14 comments Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy. Skip to main content LinkedIn

https://www.linkedin.com/feed/update/urn:li:activity:7255651295984771072/

Private workspace

Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.